| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $961.0M | +24.5% |
| Cost of Revenue | $287.2M | +6.0% |
| Gross Profit | $673.7M | +34.5% |
| R&D Expense | $302.6M | +15.0% |
| SG&A Expense | $249.5M | +16.3% |
| Operating Income | -$169.2M | +26.4% |
| Pre-tax Income | -$157.1M | +33.6% |
| Income Tax | $2.7M | +18.2% |
| Net Income | -$159.9M | +33.1% |
| EPS (Basic) | -$1.73 | +79.7% |
| EPS (Diluted) | -$1.73 | +79.7% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $428.8M | -2.9% |
| Accounts Receivable | $56.0M | +25.9% |
| Current Assets | $590.9M | +3.2% |
| Total Assets | $1.75B | -1.3% |
| Current Liabilities | $169.5M | +10.7% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $219.8M | -30.0% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $110.1M | +197.2% |
| Capital Expenditures | $4.7M | +23.8% |
| Investing Cash Flow | -$44.8M | -96.8% |
| Financing Cash Flow | -$78.8M | -128.2% |
| Free Cash Flow | $105.4M | +217.0% |
| $1.53B |
| +4.9% |